Celgene Corporation (CELG)
(Delayed Data from NSDQ)
$96.88 USD
+1.67 (1.75%)
Updated May 3, 2019 04:00 PM ET
After-Market: $96.84 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[CELG]
Reports for Purchase
Showing records 361 - 371 ( 371 total )
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet.
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Q4:09 Financial Results and 2010 Guidance; Raising Our Price Target to $69 from $68.
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Reports Solid 4Q09, Provides Conservative FY10 EPS Guidance; Reiterate Buy
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Previewing 4Q09 Earnings; Reiterating Buy Rating
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.
Industry: Medical - Biomedical and Genetics
Q4:09 Financial Preview and Lowering Forward EPS Estimates Due to Anticipated Increased R/D Spend
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Industry: Medical - Biomedical and Genetics
Top Picks of 2010 : Focusing on the Leaders Within Each Sector
Provider: MERRIMAN CURHAN FORD & CO.